Medical Exoskeleton Market, By Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Global Medical Exoskeleton market is anticipated to reach USD 138.6 million in 2021 growing at a CAGR of 45.2% during the forecasting period, 2021-2028.
Medical exoskeleton are the devices that are designed to restore and help the patient to regain the motility of the affected part. Examples include ankle exos for foot drop disease, hip exos for rehab. With the technological advancements occuring in the sector the exos have become lighter and more user friendly. Their application is not only restricted to medical industry but they also find use in warehouses, robotics and military.
Increasing orthopaedic disease cases and foot and ankle disorders are some of the factors that have supported long-term expansion for Medical Exoskeleton industry.
Global Medical Exoskeleton market is segmented into Component, Type, Extremities, Mobility and geography.
Component segment is segmented into Hardware (Sensor, Actuator, Control System, Power Source), Software
Type segment is segmented into Powered, Passive
Extremities segment is segmented into Lower, Upper
Mobility segment is segmented into Mobile, Stationary
Geographically, global Medical Exoskeleton market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Key players in global Medical Exoskeleton market are Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd (Israel), Parker Hannifin Corp (US), Bionik Laboratories Corp (Canada), CYBERDYNE Inc. (Japan), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (A Subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet, (Russia) among others.
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 138.6 million |
Growth Rate |
CAGR of 45.2% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
Component, Type, Extremities, Mobility and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd (Israel), Parker Hannifin Corp (US), Bionik Laboratories Corp (Canada), CYBERDYNE Inc. (Japan), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (A Subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet, (Russia) |
Available Customization |
In addition to the market data for Medical Exoskeleton market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |